newsfilter
← Latest News
ClinicalTrials.gov·

A Study Evaluating B Cell Levels In Infants Of Lactating Women With CIS Or MS Receiving Ocrelizumab - NCT04998851

Proportion of infants with B cell levels (CD19+ cells) below the lower limit of normal (LLN), Estimated average oral daily infant dosage (ADID), B cell levels (CD19+ cells) in the infant, (and 10 more...)